News

Sleep disorders contribute to mental health challenges, traumatic injuries, and increased health care utilization in active-duty service members.
The FDA has updated the labeling for Kisunlaâ„¢ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.